Brief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
09/03/2021 13:23
March 9 (Reuters) - Aptahem AB APTA.TE :
* APTAHEM SIGNS A NON BINDING TERM SHEET FOR DEVELOPMENT,
MANUFACTURING AND DISTRIBUTION OF APTA-1 FOR SEPSIS IN EUROPE
* ANNOUNCE TODAY THAT COMPANY HAS SIGNED AN NBTS (NON
BINDING TERM
SHEET) WITH A MID-SIZED PHARMACEUTICAL COMPANY WITH HEAD
QUARTERS IN EUROPE.
* NBTS RELATES TO LICENSE TERMS FOR EXCLUSIVE DEVELOPMENT,
MANUFACTURING AND DISTRIBUTION OF APTA-1 FOR TREATMENT OF SEPSIS
IN EUROPE.
Source text for Eikon: ID:nWkr4VtlcD
Further company coverage: APTA.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman